文献速递糖尿病肥胖与代谢综合征

CREBRF rs373863828 A等位基因与毛利及太平洋岛民BMI升高但2型糖尿病风险降低的矛盾关联

Discordant association of the CREBRF rs373863828 A allele with increased BMI and protection from type 2 diabetes in Māori and Pacific (Polynesian) people living in Aotearoa/New Zealand.
PubMed 文献 · Diabetologia · 2018-05-02

在新西兰2286名毛利及太平洋岛民成年人中,CREBRF rs373863828 A等位基因与对数转换BMI效应量0.038(95%CI 0.022,0.055,p=4.8×10⁻⁶)相关,并与2型糖尿病风险降低相关(OR 0.59,95%CI 0.47,0.73,p=1.9×10⁻⁶),未发现与尿酸、痛风或慢性肾病关联。

要点

  • A等位基因与对数转换BMI正相关,效应量0.038(95%CI 0.022,0.055)。
  • A等位基因与2型糖尿病风险降低相关,OR 0.59(95%CI 0.47,0.73)。
  • 未发现A等位基因与血清尿酸、痛风或慢性肾病存在关联证据。

核心结论

  • 在新西兰波利尼西亚成年人中,CREBRF rs373863828 A等位基因与更高BMI但更低2型糖尿病风险相关,效应量与萨摩亚成年人中的报道非常相似。

研究设计与样本

  • 采用线性与逻辑回归模型分析2286名新西兰毛利及太平洋岛民成年人中CREBRF rs373863828 A等位基因与BMI、对数转换BMI、腰围、2型糖尿病、痛风及慢性肾病的关联,主要分析按祖先定义分组并进行荟萃分析合并效应。

主要发现

  • A等位基因对对数转换BMI的效应量为0.038(95%CI 0.022,0.055,p=4.8×10⁻⁶),对2型糖尿病的OR为0.59(95%CI 0.47,0.73,p=1.9×10⁻⁶)。
  • 未发现基因型与BMI方差相关的证据(p=0.13)。
  • 未发现与血清尿酸(β=0.012 mmol/l,pcorrected=0.10)、痛风(OR 1.00,p=0.98)或慢性肾病(OR 0.91,p=0.59)存在关联的证据。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The A (minor) allele of CREBRF rs373863828 has been associated with increased BMI and reduced risk of type 2 diabetes in the Samoan populations of Samoa and American Samoa. Our aim was to test rs373863828 for associations with BMI and the odds of type 2 diabetes, gout and chronic kidney disease (CKD) in Māori and Pacific (Polynesian) people living in Aotearoa/New Zealand. METHODS: Linear and logistic regression models were used to analyse the association of the A allele of CREBRF rs373863828 with BMI, log-transformed BMI, waist circumference, type 2 diabetes, gout and CKD in 2286 adults. The primary analyses were adjusted for age, sex, the first four genome-wide principal components and (where appropriate) BMI, waist circumference and type 2 diabetes. The primary analysis was conducted in ancestrally defined groups and association effects were combined using meta-analysis. RESULTS: For the A allele of rs373863828, the effect size was 0.038 (95% CI 0.022, 0.055, p = 4.8 × 10-6) for log-transformed BMI, with OR 0.59 (95% CI 0.47, 0.73, p = 1.9 × 10-6) for type 2 diabetes. There was no evidence for an association of genotype with variance in BMI (p = 0.13), and nor was there evidence for associations with serum urate (β = 0.012 mmol/l, pcorrected = 0.10), gout (OR 1.00, p = 0.98) or CKD (OR 0.91, p = 0.59). CONCLUSIONS/INTERPRETATION: Our results in New Zealand Polynesian adults replicate, with very similar effect sizes, the association of the A allele of rs373863828 with higher BMI but lower odds of type 2 diabetes among Samoan adults living in Samoa and American Samoa.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Krishnan M, Major TJ, Topless RK, et al. Discordant association of the CREBRF rs373863828 A allele with increased BMI and protection from type 2 diabetes in Māori and Pacific (Polynesian) people living in Aotearoa/New Zealand. Diabetologia. 2018. PMID: 29721634. doi:10.1007/s00125-018-4623-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。